Real-time enrollment status for this pulmonary hypertension clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 12:06 PM UTC
| NCT Number | NCT05983250 |
| Recruiting Status | Recruiting |
| Condition | Pulmonary Hypertension |
| Phase | Clinical Trial |
| Target Enrollment | 230 participants |
| Active Locations | 51 sites in the US |
| Sponsor | Tenax Therapeutics, Inc. |
| Last Updated on CT.gov | February 18, 2026 (1 week ago) |
As of March 2, 2026: Clinical trial NCT05983250 is currently recruiting participants. This clinical trial study for pulmonary hypertension is actively seeking new participants at 51 locations across the United States. The study is sponsored by Tenax Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05983250 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 51 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05983250 was last updated 1 week ago (February 18, 2026). HelloStudys verifies this status automatically.